Alkermes reflects during National Minority Mental Health Month

Posted 7 minutes ago

Proposed by Alkermes

April marks National Minority Health Month, a time for us to reflect on the work that remains to be done to break down and break down the existing barriers that prevent minority communities from seeking mental health care. While many factors can contribute to inequality, there are resources that can help close the gap.

About Alkermes

Alkermes plc is a fully integrated global biopharmaceutical company developing innovative medicines in the areas of neuroscience and oncology. The Company has a pipeline of proprietary commercial products focused on alcohol addiction, opioid addiction, schizophrenia and bipolar I disorder, as well as a pipeline of product candidates in development for neurodegenerative disorders and cancer. Based in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit the Alkermes website at www.alkermes.com.

Alkermes

Alkermes

Alkermes plc is a fully integrated global biopharmaceutical company developing innovative medicines in the areas of neuroscience and oncology. The Company has a pipeline of proprietary commercial products focused on alcohol addiction, opioid addiction, schizophrenia and bipolar I disorder, as well as a pipeline of product candidates in development for neurodegenerative disorders and cancer. Based in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit the Alkermes website at www.alkermes.com.

More than Alkermes

Leave a Comment